Medline ® Abstract for Reference 2
of 'Hepatitis A virus infection: Prevention'
Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep. 2007;56(41):1080.
In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged>or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.